Serial entrepreneur Niklas Kouparanis has shaped the future of the European cannabis industry since 2017 as a medical cannabis pioneer, founder, and growth activator. In 2020, he co-founded Bloomwell Group, which is among Europe’s largest telemedical cannabis companies. Bloomwell Group serves as a central hub for a cannabis ecosystem that covers the entire value chain with the exception of cultivation. Through digitization of the treatment process, Bloomwell facilitates a reliable supply of medical cannabis to patients and contributes to the destigmatization of the plant in medicine through data-based research.
On April 1, 2024, Germany implemented the Cannabis Act (CanG), which reclassified cannabis as a non-narcotic. The legislation made medical cannabis more accessible to...